Albumin-bound paclitaxel (ABI-007; Abraxane) in the management of basal-like breast carcinoma

被引:13
作者
Altundag, Kadri [1 ]
Dede, Didem S.
Purnak, Tugrul
机构
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Internal Med, Ankara, Turkey
关键词
D O I
10.1136/jcp.2006.042481
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:958 / 958
页数:1
相关论文
共 5 条
[1]   Basal-like breast carcinomas: clinical outcome and response to chemotherapy [J].
Banerjee, S. ;
Reis-Filho, J. S. ;
Ashley, S. ;
Steele, D. ;
Ashworth, A. ;
Lakhani, S. R. ;
Smith, I. E. .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (07) :729-735
[2]  
DESAI N, 2003, 26 ANN SAN ANT BREAS, P3
[3]   Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer [J].
Gradishar, WJ ;
Tjulandin, S ;
Davidson, N ;
Shaw, H ;
Desai, N ;
Bhar, P ;
Hawkins, M ;
O'Shaughnessy, J .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7794-7803
[4]   Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer [J].
Rodriguez Pinilla, Socorro Maria ;
Honrado, Emiliano ;
Hardisson, David ;
Benitez, Javier ;
Palacios, Jose .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 99 (01) :85-90
[5]   Breast cancer molecular subtypes respond differently to preoperative chemotherapy [J].
Rouzier, R ;
Perou, CM ;
Symmans, WF ;
Ibrahim, N ;
Cristofanilli, M ;
Anderson, K ;
Hess, KR ;
Stec, J ;
Ayers, M ;
Wagner, P ;
Morandi, P ;
Fan, C ;
Rabiul, I ;
Ross, JS ;
Hortobagyi, GN ;
Pusztai, L .
CLINICAL CANCER RESEARCH, 2005, 11 (16) :5678-5685